Regular Article
Short-Chain 3-Hydroxy-2-methylacyl-CoA Dehydrogenase from Rat Liver: Purification and Characterization of a Novel Enzyme of Isoleucine Metabolism

https://doi.org/10.1006/abbi.1995.1388Get rights and content

Abstract

Short-chain L-3-hydroxy-2-methylacyl-CoA dehydrogenase (SC-HMAD), a soluble mitochondrial enzyme, was purified 6000-fold from rat Liver in 6% yield by a six-step purification procedure. The purified enzyme was homogenous as judged by gel electrophoresis in the presence of sodium dodecyl sulfate. The molecular mass of this protein was estimated to be 28 kDa under denaturing conditions. Under nondenaturing conditions, the enzyme behaved on Sephacryl S-200 like serum albumin with a molecular mass of 66 kDa. Thus, SC-HMAD seems to be a dimer composed of two, most likely identical 28-kDa subunits. Immunoblotting with antibodies to pig heart L-3-hydroxyacyl-CoA dehydrogenase (HAD) (EC 1.1.1.35) revealed that SC-HMAD and HAD are immunologically unrelated proteins. SC-HMAD, but not HAD, catalyzes the NAD+-dependent dehydrogenation of L-3-hydroxy-2-methybutyryl-CoA, a metabolite of isoleucine, to 2-methylacetoacetyl-CoA. Relative activities with 3-hydroxy-2-methylacyl-CoA thioesters having acyl chains with 4, 5, 10, and 16 carbon atoms are 88, 100, 16, and 0%, respectively. Unbranched 3-hydroxyacyl-CoA thioesters are also substrates of SC-HMAD, although poorer ones as evidenced by apparent Km values of 5 and 19 μM for L-3-hydroxy-2-methylbutyryl-CoA and L-3-hydroxybutyryl-CoA, respectively. Maximal velocities observed with these two substrates were similar. It is concluded that SC-HMAD catalyzes the second dehydrogenation step during the β-oxidation of the isoleucine metabolite 2-methylbutyryl-CoA. This enzyme may also be involved in the β-oxidation of natural and xenobiotic branched chain carboxylic acids.

References (0)

Cited by (41)

  • Structural and mechanistic basis of RNA processing by protein-only ribonuclease P enzymes

    2022, Trends in Biochemical Sciences
    Citation Excerpt :

    In contrast to the widespread ssPRORPs, msPRORPs have thus far only been found in mitochondria of metazoans [21,50]. In humans, the mtRNase P is a trimeric complex comprised of an endonuclease, a methyltransferase, and a fatty acid/sterol dehydrogenase [21,51,52]. Its nucleolytic subunit Homo sapiens PRORP (hsPRORP; also known as MRPP3) is an orthologue of ssPRORPs and exhibits a high degree of sequence similarity to the ssPRORPs from A. thaliana and T. brucei [23,53].

  • 17B-hydroxysteroid dehydrogenases as acyl thioester metabolizing enzymes

    2019, Molecular and Cellular Endocrinology
    Citation Excerpt :

    It may seem prudent to therefore refer to HSD17B10 as a multitasking rather than multifunctional protein to distinguish between these arrangements. The protein was initially purified from rat liver as 3-hydroxy-2-methylacyl-CoA dehydrogenase of isoleucine metabolism (Luo et al., 1995) and cloned as short-chain 3S-hydroxyacyl-CoA dehydrogenase (SCHAD) involved in β-oxidation by screening of a human liver cDNA library (Vredendaal et al., 1996) for the homolog of an enzyme that had been previously isolated from pig heart (Noyes and Bradshaw, 1973). The same protein was also cloned by screening a bovine liver cDNA expression library using antibody raised against the purified 3-hydroxyacyl-CoA dehydrogenase type II (HADH2) (Furuta et al., 1997).

  • 17β-Hydroxysteroid dehydrogenases and neurosteroid metabolism in the central nervous system

    2019, Molecular and Cellular Endocrinology
    Citation Excerpt :

    Each subunit has 261 amino acid residues with an isoelectric pH 7.65. Its rat homolog was first isolated from rat liver and characterized as a 2-methyl-3-hydroxyacyl dehydrogenase essential for the catalysis of the isoleucine degradation pathway (Luo et al., 1995). Thereafter, a bovine homolog was isolated from bovine liver as type II 3-hydroxyacyl-CoA dehydrogenase (Kobayashi et al., 1996).

  • Serum metabolomics study in a group of Parkinson's disease patients from northern India

    2018, Clinica Chimica Acta
    Citation Excerpt :

    2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) is a mitochondrial enzyme involved in the catabolism of isoleucine and branched-chain fatty acids. MHBD deficiency causes impaired catabolism of isoleucine presenting as neurodegenerative disease [7]. Glutamate metabolism changes take place in many neurodegenerative pathologies, and the disruptions may be related to changes of glutamate metabolism enzyme activities, alterations of the main energy formation reactions in mitochondria, and shifts of oxidation/redox balance in cells.

  • Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase and mitochondrial tRNA modification functions of the encoded protein

    2017, Biochimica et Biophysica Acta - Molecular Basis of Disease
    Citation Excerpt :

    HSD10/MRPP2 belongs to the family of NAD(P)(H)-dependent short-chain dehydrogenase/reductases (SDR) [1–3], and was first identified as the dehydrogenase enzyme L-2-methyl-3-hydroxyacyl-CoA dehydrogenase (L-methyl-3-HAD) that converts L-2-methyl-3-hydroxybutyryl-CoA to 2-methyl-acetoacetyl-CoA, the penultimate step of isoleucine metabolism by β-oxidation [4]. Since then, many in vitro SDR substrates have been identified for HSD10/MRPP2 including the sex hormone 17β-estradiol [5,6], bile acids [7], the neurosteroid allopregnanolone [8], and short straight-chain/branched-chain fatty acyl-CoA thioesters [9]. The protein is also known to be inhibited by amyloid-β peptide [10,11].

View all citing articles on Scopus
View full text